UBS Maintains 'Neutral' on Luminex (LMNX); Strong 2Q, Increasing Momentum

UBS maintains 'Neutral' on Luminex (NASDAQ: LMNX), adjusts price target from $21.00 to $20.50.

UBS analyst says, "Revenues and EPS beat Street on solid system & consumables growth...Magpix seeing traction; new assay products set to contribute...For ‘11, LMNX now sees sales of $180-185m (+27-31%), up from $163-170m previously, & with $5-7m from M&A. We project ’11 revs of $183m, with EPS of $0.37 (was $0.32). For ’12E, we see sales of $220m, with EPS of $0.58 (was $0.56)."

For more ratings news on Luminex click here and for the rating history of Luminex click here.

Shares of Luminex closed at $18.50 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BRF - Brasil Foods S.A. (BRFS3:BZ) (BRFS) PT Raised to BRL19 at Itau BBA
• Itau BBA Reiterates Outperform Rating on JBS SA (JBSS3:BZ) (JBSAY)
• Itau BBA Reiterates Market Perform Rating on C&A Modas Ltda (CEAB3:BZ)